Real World Prostate Cancer Registry
Launched by CINCINNATI CANCER ADVISORS · Apr 4, 2024
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
The Real World Prostate Cancer Registry (RWPCR) is a clinical trial that aims to gather important information about how prostate cancer affects men in the tristate area, which includes Greater Cincinnati, Northern Kentucky, and Southeast Indiana. This study is looking for men aged 18 and older who have been diagnosed with prostate cancer within the last year. Participants must have a confirmed diagnosis and be willing to sign a consent form. The trial will not include those with other types of cancer, except for certain skin cancers.
If you decide to take part in this registry, you'll be helping researchers understand the real-life experiences of prostate cancer patients. The study will collect information over time about your health, treatments, and outcomes, which can help improve care for future patients. Your participation can make a difference in how prostate cancer is understood and managed, and it’s a valuable opportunity to contribute to important health research.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • All patients with pathologically confirmed primary prostate cancer
- • Diagnosis since January 1st, 2023
- • Acceptance to sign the consent form
- • 18 years old or older
- • Resident of Ohio, Kentucky or Indiana
- Exclusion Criteria:
- • Having diagnosis of other cancer except squamous cell cancer of the skin
- • Refusal to sign a consent form.
About Cincinnati Cancer Advisors
Cincinnati Cancer Advisors is a leading clinical trial sponsor dedicated to advancing cancer care through innovative research and patient-centered approaches. With a team of highly experienced oncologists and researchers, the organization focuses on developing and facilitating groundbreaking clinical trials that aim to improve treatment outcomes and enhance the quality of life for cancer patients. By collaborating with top-tier medical institutions and leveraging cutting-edge technology, Cincinnati Cancer Advisors is committed to exploring novel therapies and providing patients with access to the latest advancements in cancer treatment. Their mission is to empower patients through personalized care and to contribute significantly to the evolving landscape of oncology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cincinnati, Ohio, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported